In about 90% of tumors, the genetic driver event involves a mutation in the glutamate receptor gene, GRM1, which seems unique to chondromyxoid fibroma and is rare to absent in other cartilaginous tumors. This evidence concerns the gene GRM1 and chondromyxoid fibroma.